These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 11145762)
1. Rationale and design of a randomized clinical trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with advanced heart failure: the Multicenter InSync Randomized Clinical Evaluation (MIRACLE). Abraham WT J Card Fail; 2000 Dec; 6(4):369-80. PubMed ID: 11145762 [TBL] [Abstract][Full Text] [Related]
2. Cardiac resynchronization therapy for the management of chronic heart failure. Abraham WT Am Heart Hosp J; 2003; 1(1):55-61. PubMed ID: 15785177 [TBL] [Abstract][Full Text] [Related]
4. Cardiac resynchronization therapy in patients with heart failure and conduction abnormalities other than left bundle-branch block: analysis of the Multicenter InSync Randomized Clinical Evaluation (MIRACLE). Aranda JM; Conti JB; Johnson JW; Petersen-Stejskal S; Curtis AB Clin Cardiol; 2004 Dec; 27(12):678-82. PubMed ID: 15628109 [TBL] [Abstract][Full Text] [Related]
5. Clinical predictors and timing of New York Heart Association class improvement with cardiac resynchronization therapy in patients with advanced chronic heart failure: results from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) and Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE-ICD) trials. Pires LA; Abraham WT; Young JB; Johnson KM; Am Heart J; 2006 Apr; 151(4):837-43. PubMed ID: 16569543 [TBL] [Abstract][Full Text] [Related]
6. Rationale and design of a randomized controlled trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with asymptomatic left ventricular dysfunction with previous symptoms or mild heart failure--the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study. Linde C; Gold M; Abraham WT; Daubert JC; Am Heart J; 2006 Feb; 151(2):288-94. PubMed ID: 16442890 [TBL] [Abstract][Full Text] [Related]
7. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. Young JB; Abraham WT; Smith AL; Leon AR; Lieberman R; Wilkoff B; Canby RC; Schroeder JS; Liem LB; Hall S; Wheelan K; JAMA; 2003 May; 289(20):2685-94. PubMed ID: 12771115 [TBL] [Abstract][Full Text] [Related]
8. Cardiac resynchronization therapy in patients with chronic heart failure: pathophysiology and current experience. Seidl K; Rameken M; Vater M; Senges J Am J Cardiovasc Drugs; 2002; 2(4):219-26. PubMed ID: 14727967 [TBL] [Abstract][Full Text] [Related]
9. Safety of transvenous cardiac resynchronization system implantation in patients with chronic heart failure: combined results of over 2,000 patients from a multicenter study program. León AR; Abraham WT; Curtis AB; Daubert JP; Fisher WG; Gurley J; Hayes DL; Lieberman R; Petersen-Stejskal S; Wheelan K; J Am Coll Cardiol; 2005 Dec; 46(12):2348-56. PubMed ID: 16360070 [TBL] [Abstract][Full Text] [Related]
10. Cardiac resynchronization therapy in patients with right bundle branch block: analysis of pooled data from the MIRACLE and Contak CD trials. Egoavil CA; Ho RT; Greenspon AJ; Pavri BB Heart Rhythm; 2005 Jun; 2(6):611-5. PubMed ID: 15922268 [TBL] [Abstract][Full Text] [Related]
11. A comparison of cardiac resynchronization by sequential biventricular pacing and left ventricular pacing to simultaneous biventricular pacing: rationale and design of the DECREASE-HF clinical trial. De Lurgio DB; Foster E; Higginbotham MB; Larntz K; Saxon LA J Card Fail; 2005 Apr; 11(3):233-9. PubMed ID: 15812753 [TBL] [Abstract][Full Text] [Related]
12. Systematic review: cardiac resynchronization in patients with symptomatic heart failure. McAlister FA; Ezekowitz JA; Wiebe N; Rowe B; Spooner C; Crumley E; Hartling L; Klassen T; Abraham W Ann Intern Med; 2004 Sep; 141(5):381-90. PubMed ID: 15353430 [TBL] [Abstract][Full Text] [Related]
13. Feasibility, safety, and mid-term efficacy of cardiac resynchronization therapy in patients with severe heart failure and ventricular conduction delay: Chulalongkorn experience. Sunsaneewitayakul B; Sitthisook S; Sangwatanaroj S; Prechawat S; Songmuang SB J Med Assoc Thai; 2007 Jul; 90(7):1458-66. PubMed ID: 17710992 [TBL] [Abstract][Full Text] [Related]
14. Cardiac resynchronization therapy in chronic heart failure with moderately reduced left ventricular ejection fraction: Lessons from the Multicenter InSync Randomized Clinical Evaluation MIRACLE EF study. Linde C; Curtis AB; Fonarow GC; Lee K; Little W; Tang A; Levya F; Momomura S; Manrodt C; Bergemann T; Cowie MR Int J Cardiol; 2016 Jan; 202():349-55. PubMed ID: 26426276 [TBL] [Abstract][Full Text] [Related]
15. Does cardiac resynchronisation therapy improve survival and quality of life in patients with end-stage heart failure? Turley AJ; Raja SG; Salhiyyah K; Nagarajan K Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1141-6. PubMed ID: 18541605 [TBL] [Abstract][Full Text] [Related]